Evaluation of Teriparatide for Treatment of Osteoporosis in Four Patients with Cystic Fibrosis: A Case Series
Introduction. Bone disease is a common complication of cystic fibrosis (CF). To date, there have been no reports on the effectiveness of teriparatide, recombinant human parathyroid hormone, to treat CF-related bone disease. Case Presentation. We report on four patients with CF-related bone disease w...
Saved in:
| Main Authors: | Oranan Siwamogsatham, Kelly Stephens, Vin Tangpricha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2014/893589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment
by: Crystal Cobb, et al.
Published: (2025-04-01) -
Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01) -
EXPERIENCE OF LONG-TERM TERIPARATIDE USE FOR THE TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM ASSOCIATED WITH OSTEOPOROSIS IN ELDERLY PATIENT
by: G. A. Batrak, et al.
Published: (2018-11-01) -
The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
by: Olga Mikhailovna Lesnyak
Published: (2013-10-01) -
Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trial
by: Huan Wang, et al.
Published: (2025-07-01)